Plexxikon
Engages in the discovery and development of small molecule pharmaceuticals to treat human disease.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD46—70m (Dealroom.co estimates Mar 2005.)
Berkeley California (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
$26.9m | Early VC | ||
$46.0m | Series B | ||
| N/A | $7.5m | Series B | |
$935m | Acquisition | ||
| Total Funding | AUD124m | ||
